A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
Clinical trial NCT06540391 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06540391
- Sponsor
- Microbiotica Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-28
- Primary completion
- 2025-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.